NO20006350D0 - Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer - Google Patents

Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer

Info

Publication number
NO20006350D0
NO20006350D0 NO20006350A NO20006350A NO20006350D0 NO 20006350 D0 NO20006350 D0 NO 20006350D0 NO 20006350 A NO20006350 A NO 20006350A NO 20006350 A NO20006350 A NO 20006350A NO 20006350 D0 NO20006350 D0 NO 20006350D0
Authority
NO
Norway
Prior art keywords
cephemer
bipyrrolidinyl
oxo
derivatives
ylidene methyl
Prior art date
Application number
NO20006350A
Other languages
English (en)
Norwegian (no)
Other versions
NO20006350L (no
Inventor
Paul Hebeisen
Christian Hubschwerlen
Jean-Luc Specklin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20006350L publication Critical patent/NO20006350L/no
Publication of NO20006350D0 publication Critical patent/NO20006350D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20006350A 1998-06-15 2000-12-13 Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer NO20006350D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98110888 1998-06-15
EP98117099 1998-09-10
PCT/EP1999/003907 WO1999065920A1 (en) 1998-06-15 1999-06-07 Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems

Publications (2)

Publication Number Publication Date
NO20006350L NO20006350L (no) 2000-12-13
NO20006350D0 true NO20006350D0 (no) 2000-12-13

Family

ID=26149347

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006350A NO20006350D0 (no) 1998-06-15 2000-12-13 Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer

Country Status (28)

Country Link
EP (1) EP1087980B1 (da)
JP (1) JP3872955B2 (da)
KR (1) KR100411915B1 (da)
CN (1) CN1136222C (da)
AR (1) AR018675A1 (da)
AT (1) ATE231871T1 (da)
AU (1) AU754732B2 (da)
BE (1) BE2014C034I2 (da)
BR (2) BRPI9911178C1 (da)
CA (1) CA2334568C (da)
CO (1) CO5080758A1 (da)
DE (1) DE69905162T2 (da)
DK (1) DK1087980T3 (da)
ES (1) ES2190222T3 (da)
FR (1) FR14C0044I2 (da)
GT (1) GT199900084A (da)
HU (1) HUP0105426A3 (da)
ID (1) ID27686A (da)
IL (1) IL139872A0 (da)
LU (1) LU92564I2 (da)
MA (1) MA26650A1 (da)
NO (1) NO20006350D0 (da)
PA (1) PA8475701A1 (da)
PE (1) PE20000645A1 (da)
PL (1) PL344994A1 (da)
SV (1) SV1999000075A (da)
TN (1) TNSN99114A1 (da)
WO (1) WO1999065920A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001004127A1 (en) * 1999-07-07 2001-01-18 F. Hoffmann-La Roche Ag Vinylpyrrolidinone derivatives with substituted thiazole ring
EP1148140B1 (en) 2000-04-19 2006-10-04 Basilea Pharmaceutica AG Process for the preparation of D-asparagine derivatives
US6504025B2 (en) * 2000-05-24 2003-01-07 Basilea Pharmaceutica Ag Process for the preparation of vinyl-pyrrolidinone cephalosporin derivatives
PL1606293T3 (pl) * 2003-03-27 2010-01-29 Basilea Pharmaceutica Ag Cefalosporyna w postaci krystalicznej
EP1656930A1 (en) * 2004-11-10 2006-05-17 Basilea Pharmaceutica AG Stabilized freeze-dried formulation for cephalosporin derivatives
AR071318A1 (es) 2008-04-15 2010-06-09 Basilea Pharmaceutica Ag Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso
WO2010072672A1 (en) 2008-12-24 2010-07-01 Basilea Pharmaceutica Ag New crystal polymorphs of ceftobiprole
US9139597B2 (en) 2009-05-25 2015-09-22 Sandoz Ag Method for the production of ceftobiprole medocaril
PL2569321T3 (pl) 2010-05-10 2015-07-31 Basilea Pharmaceutica Int Ltd Sposób utleniania do otrzymywania pochodnych 3-formylo-cefemu

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE354577T1 (de) * 1996-11-06 2007-03-15 Basilea Pharmaceutica Ag Vinylpyrrolidinon-cephalosporin-derivate
TW415949B (en) * 1996-12-19 2000-12-21 Hoffmann La Roche Vinyl pyrrolidine cephalosporin derivatives with basic substituents

Also Published As

Publication number Publication date
MA26650A1 (fr) 2004-12-20
CA2334568C (en) 2009-02-24
FR14C0044I1 (da) 2014-07-18
KR100411915B1 (ko) 2003-12-18
FR14C0044I2 (fr) 2015-02-20
CN1136222C (zh) 2004-01-28
DE69905162D1 (de) 2003-03-06
ID27686A (id) 2001-04-19
BRPI9911178C1 (pt) 2021-05-25
NO20006350L (no) 2000-12-13
AU4508199A (en) 2000-01-05
TNSN99114A1 (fr) 2005-11-10
ATE231871T1 (de) 2003-02-15
CA2334568A1 (en) 1999-12-23
AR018675A1 (es) 2001-11-28
PE20000645A1 (es) 2000-07-26
BRPI9911178B8 (pt) 2017-03-07
SV1999000075A (es) 2000-05-02
EP1087980B1 (en) 2003-01-29
KR20010052866A (ko) 2001-06-25
CN1305484A (zh) 2001-07-25
BE2014C034I2 (en) 2018-08-24
HUP0105426A2 (hu) 2002-05-29
JP2002518401A (ja) 2002-06-25
DE69905162T2 (de) 2003-12-24
HUP0105426A3 (en) 2002-12-28
CO5080758A1 (es) 2001-09-25
WO1999065920A1 (en) 1999-12-23
LU92564I2 (fr) 2014-12-01
BR9911178A (pt) 2001-03-13
PA8475701A1 (es) 2000-09-29
PL344994A1 (en) 2001-11-19
DK1087980T3 (da) 2003-05-26
GT199900084A (es) 2000-12-05
ES2190222T3 (es) 2003-07-16
BR9911178B1 (pt) 2013-10-29
JP3872955B2 (ja) 2007-01-24
IL139872A0 (en) 2002-02-10
AU754732B2 (en) 2002-11-21
EP1087980A1 (en) 2001-04-04

Similar Documents

Publication Publication Date Title
DE69907964D1 (de) 1,2-annelierte chinolinderivate
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
MA26816A1 (fr) Derives d'amino-triazolopyridine
DE69933287D1 (de) 12,13-modifizierte epothilon-derivate
HUP0100779A3 (en) Novel derivatives of 3,3-diphenylpropylamines
MA26932A1 (fr) Derives d'imidazole.
FR14C0044I2 (fr) Derives de 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephemes
DK0842143T5 (da) 2-(4-substituerede)-benzylamino-2-methyl-propanamid derivater
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
MA24632A1 (fr) Derives de 2-(4-aryl-ou heteroaryl-piperazine-1-ylmethyle)-1h- indole
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
ATE219067T1 (de) Substituierte (2-(1-piperazinyl)ethoxy)methyl- derivate
EE04089B1 (et) 1,3,4-oksadiasolooni derivaadid
DE69907161D1 (de) 5' deoxycytidin-derivative
PT963985E (pt) Derivados de di- ou triaza-espiro(4,5)decano
ATE243218T1 (de) 2''-deoxyhygromycinderivate
NO20016030D0 (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
PT796843E (pt) Derivados de 1,25-di-hidroxi-16,22,23-trisde-hidro-colecalciferol
NO20015397D0 (no) 1,5-Benzodiazepin-derivater
NO20005856L (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
FI980405A0 (fi) Industriellt, kontinuerligt foerfarande foer framstaellning av "gravkalk"
NO20012028L (no) Fremgangsmåte for fremstilling av 4-((2',5'-diamino-6'- halogenpyrimidin-4'-yl)amino)-cyclopent-2-enyl-metanoler
DK1175397T3 (da) 3,3-substituerede indolinderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application